EUVIMEDEUVIMED entdecken
Open Access

Cost-effectiveness Thresholds Used by Study Authors, 1990-2021

Peter J Neumann, David D Kim

JAMA · 18.04.2023 · 329 (15) · 1312

DOI: 10.1001/jama.2023.1792 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA, erschienen am 18.04.2023. Verfasst von Peter J Neumann und 1 weiteren Autor:innen. Beteiligte Einrichtung: Center for the Evaluation of Value and Risk in Health, Tufts Medical Center, Boston, Massachusetts. Hauptthemen laut MEDLINE: Cost-Benefit Analysis, Cost-Effectiveness Analysis, Delivery of Health Care. Die Arbeit wurde bisher 193-mal zitiert (Crossref) und nennt 6 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study examines what study authors consider to be appropriate cost-effectiveness analysis thresholds as reflected in the referenced thresholds in their published cost-effectiveness analyses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cost-Benefit AnalysisCost-Effectiveness AnalysisDelivery of Health CareDeveloping CountriesQuality-Adjusted Life Years

Autor:innen und Institutionen

  • Center for the Evaluation of Value and Risk in Health, Tufts Medical Center, Boston, Massachusetts.
  • Department of Medicine, University of Chicago, Chicago, Illinois.

Zitieren

APA

Neumann, P. J., & Kim, D. D. (2023). Cost-effectiveness Thresholds Used by Study Authors, 1990-2021. JAMA, 329(15), 1312. https://doi.org/10.1001/jama.2023.1792

Vancouver

Neumann PJ, Kim DD. Cost-effectiveness Thresholds Used by Study Authors, 1990-2021. JAMA. 2023;329(15):1312. doi:10.1001/jama.2023.1792

BibTeX
@article{Neumann2023,
  author = {Neumann, Peter J and Kim, David D},
  title = {Cost-effectiveness Thresholds Used by Study Authors, 1990-2021},
  journal = {JAMA},
  year = {2023},
  volume = {329},
  number = {15},
  pages = {1312},
  doi = {10.1001/jama.2023.1792}
}
Kostenlos starten →